Chief Operating Officer and Chief Financial Officer · NEKTAR THERAPEUTICS (NKTR)

Gil Labrucherie

A named executive officer of NEKTAR THERAPEUTICS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$5,285,922

Salary $788,000Stock awards $2,247,676

FY2019: $7,488,841

2nd of 5 named executive officers at Nektar Therapeutics by FY2020 total.

5 named officers on file for NEKTAR THERAPEUTICS, FY2020

Gil Labrucherie’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 16 equity grants, each cited to its filing
  • NKTR’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NEKTAR THERAPEUTICS’s whole pay program stands against its peers

  • NEKTAR THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NKTR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Gil Labrucherie’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Gil Labrucherie compensation by year

NEKTAR THERAPEUTICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as NEKTAR THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$582,167$607,400$631,696$683,325$788,000
Bonus$0$0$0——
Stock awards$489,596$2,958,794$2,099,320$3,131,971$2,247,676
Option awards$1,303,120$3,672,084$2,359,382$3,661,047$1,501,672
Non-equity incentive$356,400$531,475$631,600$0$721,000
Pension and deferred compensation$0$0$0$0$0
All other$8,653$10,338$11,930$12,498$27,574
Total$2,739,936$7,780,091$5,733,928$7,488,841$5,285,922

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEKTAR THERAPEUTICS DEF 14A filed April 30, 2021, accession 0001193125-21-143681, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NEKTAR THERAPEUTICS filed document, accession 0001193125-21-143681. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

$2.7M
$7.8M
$5.7M
$7.5M
$5.3M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU43,750$743,750—
PSU40,150$682,550—
RSU40,000$680,000—
PSU40,000$680,000—
PSU28,750$488,750—
PSU27,600$469,200—
RSU26,767$455,039—
RSU9,584$162,928—
Option58,100—$36.51
Option71,550—$21.79
Option71,550—$18.75
Option16,250—$56.90

Per the Outstanding Equity Awards at Fiscal Year-End table in NEKTAR THERAPEUTICS's FY2020 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 18 award rows shown.

NEKTAR THERAPEUTICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Howard RobinPresident and Chief Executive Officer$11,241,549
Gil Labrucherie · this pageChief Operating Officer and Chief Financial Officer$5,285,922
Jonathan ZalevskyChief Research and Development Officer$4,941,497
John NorthcottSenior Vice President and Chief Commercial Officer$3,832,798
Mark WilsonSenior Vice President and General Counsel$3,455,906

The full NEKTAR THERAPEUTICS compensation record

free company brief

This page is one person within NEKTAR THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NEKTAR THERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEKTAR THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gil Labrucherie's compensation dossier · One-time report. No refunds.